GMO Benchmark-Free Allocation III
GMO Trust 40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | World Allocation | | Fund Family: | GMO | | Net Assets: | 1.74B | | Year-to-Date Return: | -1.33% | | Yield: | 3.49% | | Morningstar Rating: |  | | Fund Inception Date: | 23-Jul-03 |
|
Ben Inker
Lead Manager since
23-Jul-03 | | | Inker is the director of asset allocation. Inker joined GMO in 1992 . |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | NaN | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks a positive return regardless of market direction. The fund is a fund of funds and primarily invests in shares of other GMO Funds, which may include the International Equity Funds (including one or more of the Emerging Markets Funds), the U.S. Equity Funds, the Fixed Income Funds, Alpha Only Fund, Alternative Asset Opportunity Fund, Flexible Equities Fund, Short-Duration Collateral Fund, Special Situations Fund, and World Opportunity Overlay Fund (collectively, the ?underlying Funds?). |
| Last Dividend
(30-Dec-09):
| 0.60 | | Last Cap Gain
(7-Jul-09):
| 0.02 | | Annual Holdings Turnover
| 40.00% | | Average for Category:
| 105.43% |
|
| Expense | GBMFX | Category
Avg | | Total Expense Ratio: | 0.73%
| 1.24% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | 0.09%
| 4.97% | | Max Deferred Sales Load: | %
| 2.22% | | 3 Yr Expense Projection*: |
$ 293 | $717 | | 5 Yr Expense Projection*: |
$ 510 | $1,111 | | 10 Yr Expense Projection*: |
$ 1,135 | $2,237 |
|
|
1.52% Nasdaq 0.00%
Profile
